Shineway Biological: The holding ratio of the controlling shareholder and its concerted actors has been adjusted from 35.82% to 30.78%, with a change in equity proportion of 5.04%.

Shineway Technologies announces that the total shareholding ratio of the company's controlling shareholders and actual controllers, Nie Dongsheng, Yang Yufang, Yang Congzhou, and Wang Dongliang, has been adjusted from 35.82% to 30.78%, with a corresponding change percentage of 5.04%. This change in equity is due to a change in the company's shareholder's executing partners, leading to the termination of the unanimous action relationship among shareholders. The number of shares held by each shareholder has not changed.